REFERENCES

1. Imazio M, Bobbio M, Cecchi E, et al. Colchicine in addition to conventional therapy for acute pericarditis. Circulation. 2005;112:2012-2016.

2. Otto CM, Nishimura RA, Bonow RO, et al.

3. Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who Cannot undergo surgery. NEngl J Med. 2010;363:1597-1607.

4. Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. NEngl J Med. 2016;374:1609-1620.

5. Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. NEngl JMed. 2011;364:2187-2198.

6. Reardon MJ, Mieghem NMV, Popma JJ, et al. Surgical or transcatheter aortic-valve replacement in intermediate-risk patients. NEngl J Med. 2017;376:1321-1331.

7. Stone GW, Lindenfeld J, Abraham WT, et al. Transcatheter mitral-valve repair in patients with heart failure. NEngl JMed. 2018;379:2307-2318.

8. Mack MJ, Abraham WT, Lindenfeld J, et al. Cardiovascular outcomes assessment of the MitraClip in patients with heart failure and secondary mitral regurgitation: Design and rationale of the COAPT trial. Am Heart J. 2018;205:1-11.

9. Dujardin KS, Enriquez-Sarano M, Schaff HV, Bailey KR, Seward JB, Tajik AJ. Mortality and morbidity of aortic regurgitation in clinical practice. Circulation. 1999;99:1851-1857.

10. Maurer G. Aortic regurgitation. Heart. 2006;92:994.

11. Puri R, Auffret V, Rodes-Cabau J. Bioprosthetic valve thrombosis. J Am Coll Cardiol. 2017;69:2193-2211.